Home›People›Ala Alenazi
Ala Alenazi

Ala Alenazi

Investment and director at Strand Therapeutics.

Director
Updated Nov 10, 2026·Latest SEC filing Mar 17, 2026·Suggest an edit

About Ala Alenazi

Ala Alenazi is an investment and director at Strand Therapeutics.

Experience

This experience comes from Ala Alenazi's profile and from SEC filings. For roles taken from filings, the years are when the filings name Ala Alenazi in the role, so the role may have started earlier or lasted longer.

Strand Therapeutics Inc. Current
Investment and director
2025 – Present · Boston, MA
Develops mRNA medicines for people with cancer and autoimmune diseases.
Kinnevik Current
Investment Manager
2024 – Present
Panakeia
Board Member
2023
Tailor Bio
Board Observer
2022 – 2023
Qureight
Board Observer
2022 – 2023
AMLo Biosciences
Board Observer
2022 – 2023
Tech Nation
Judge - Libra Programme 2.0
2022 – 2023
Ascension
Principal, Life Fund
2021 – 2023
Babraham Bioscience Technologies Ltd
Expert - Accelerate@Babraham
2021 – 2023
Wayra
Healthcare Mentor
2021 – 2023
EIT Health
Expert Evaluator & Panel (Biotech)
2020 – 2023
Amazon
Operations Project Management
2019 – 2020
Cambridge Consulting Network
Engagement Manager
2017 – 2018
University of Cambridge
Project Supervisor, Department of Pathology
2016 – 2017

Key Colleagues at Startups

The people Ala Alenazi works with at each company, as listed on that company's latest Form D.

Strand Therapeutics Inc. · Form D, Mar 17, 2026
Jeb Keiper
Jeb Keiper
Independent Board Director
Pegah Ebrahimi
Pegah Ebrahimi
Co-founder & Managing Partner, FPV Ventures, director
Tasuku Kitada
Tasuku Kitada
President, Head of R&D, Co-founder, director
Samta Kundu
Samta Kundu
Chief Operating Officer
Jory Bell
Jory Bell
Director
Jacob Becraft
Jacob Becraft
CEO, Co-Founder and director

Sources

  1. SECStrand Therapeutics Inc. Form D, filed Mar 17, 2026